Discover Spravato, A Specialized Nasal Spray for Resistant Depression
Spravato (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression who haven’t responded to traditional antidepressants. Administered under medical supervision, it offers a fast-acting treatment option that may provide long-lasting symptom relief.
Unraveling the connection between chronic pain and depression – Pieces to Wellness Podcast
The very kind staff at Pieces to Wellness interviewed Dr. Steindler about this clinic – Libertas Mind and his approach to treating depression, pain, PTSD, and anxiety. Listen to learn more!
Spravato therapy
After nearly 2 decades of research, the benefits of ketamine for depression are universally recognized. As unique and transformative as ketamine is, it remains an out-of-pocket treatment and not covered by insurance.
Achieve Superior Results today for Your Depression with Spravato Nasal Spray
The STAR*D trial demonstrated that the more antidepressants a patient trial’s the less likely they are to respond overall. By the point a patient tries 3 antidepressant’s, the remission rate is only about 15% with another treatment trial. Of the patients who respond remit at level 3 of 4, 60-70% will relapse within 6 months.
